Committee weighs expanding continuous glucose monitor coverage to more patients

SB 3045, discussed before the Senate Committee on Health and Human Services, would expand insurance coverage for continuous glucose monitors (CGMs). Testimony came from a range of health agencies, medical associations and patient advocates.

Shipta (testifying for a clinical group) and multiple patient advocates said people on insulin therapy should have access to CGMs consistent with mainland carriers; one witness noted a tragic local death tied to denied access. HMSA (Walden) said the insurer has updated coverage policies to provide CGMs to members on injectable insulin but raised concerns that broader eligibility could strain supply and asked for clarity on how to prioritize scarce devices.

The committee discussed a defective‑date approach to allow the pending sunrise analysis to complete; at decision making the committee passed SB 3045 with amendments and a defective date to allow time for the analysis. The record shows the committee is aiming to preserve access for high‑need patients while seeking implementation details before final effective dates.